Pharmacovigilance Analysis of Serious Adverse Events Reported for Biologic Response Modifiers Used as Prophylaxis against Transplant Rejection: a Real-World Postmarketing Experience from the US FDA Adverse Event Reporting System (FAERS)

Background: Immunosuppression by biologic response modifiers (BRM) is a crucial component for successful organ transplantation. In addition to their variable effectiveness in the prevention of organ rejection, these medications have safety concerns that complicate therapeutic outcomes in organ trans...

Descripción completa

Detalles Bibliográficos
Autor principal: Ali, A. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Organ Transplantation Institute 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089314/
https://www.ncbi.nlm.nih.gov/pubmed/25013655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089314/
https://www.ncbi.nlm.nih.gov/pubmed/25013655

Ejemplares similares